logo
  

Abbott Laboratories Launches PediaSure SideKicks Clear For Picky Eaters

Abbott Laboratories (ABT) Wednesday announced that it has introduced PediaSure SideKicks Clear, a refreshing clear nutritional beverage that helps balance out the diet of those picky eaters who are growing fine, but still may be missing nutrients.

The new nutritional beverage is aimed for those children who often tend to be picky-eaters, and have every possibility of missing out of the protein and other essential nutrients in their daily food intake.

The global health care company claims that one 6.8 fl oz serving of PediaSure SideKicks Clear provides as much protein as one large egg, as much vitamin D as a 6 ounce yogurt cup, and as much vitamin A as a half cup of zucchini, in addition to new kid-approved flavors - Berry and Tropical Fruit. The company further added that one serving of the beverage includes 120 calories, 19 essential vitamins and minerals, including 3 essential antioxidants in a fat free formulation.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon has unveiled millions of deals worldwide that will be available during its upcoming Prime Day extravaganza. The 48-hour shopping event for Prime members kicks off July 12 at 3 a.m. EDT, offering deals of up to 79% off across various categories. These include electronics, devices, toys, beauty, fashion, and home, from top national brands and small businesses. Primal Pet Foods is recalling a single lot of Raw Frozen Primal Patties for Dogs Beef Formula due to potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves lot #W10068709 of 6-pound Raw Frozen Primal Patties with best by date of 05/22/23. The Raw Frozen Primal Patties are sold in flexible packaging in the freezer at select pet stores. The U.S. Food and Drug Administration has authorized state-licensed pharmacists to prescribe COVID-19 pill Paxlovid (nirmatrelvir and ritonavir) by drug major Pfizer Inc. to eligible patients, with certain limitations. The agency has revised the Emergency Use Authorization or EUA for Paxlovid for the authorization, which could improve access for some patients at high risk for severe covid-19.
Follow RTT